Status:

COMPLETED

Non-Linear Imaging of Skin In Vivo

Lead Sponsor:

Enspectra Health

Collaborating Sponsors:

National Institutes of Health (NIH)

National Cancer Institute (NCI)

Conditions:

Skin Cancer

Skin Condition

Eligibility:

All Genders

2-90 years

Brief Summary

The overall objective of this study is to investigate the potential for the VIO System to display microscopic skin structure in people of different age, sex, race, and skin health.

Eligibility Criteria

Inclusion

  • Subjects, ages 2 - 90 years old.
  • Subject, or guardian, if applicable, must be willing to provide written informed consent prior to enrollment and agree to comply with protocol requirements. If applicable, child must be willing to provide written assent prior to enrollment and agree to comply with protocol requirements.
  • Subject or guardian, if applicable, must have sufficient mental capacity to understand the Informed Consent and provide clinically relevant and reliable feedback regarding their experience with the device.
  • Subject and guardian, if applicable, must comply with the protocol requirements.
  • Subject or guardian, if applicable, must agree that anonymized personal data will be made available to Study Sponsor and requisite regional and international regulatory bodies.

Exclusion

  • Any general health condition or systemic disease that may represent, in the opinion of the Principal Investigator, a potential increased risk associated with device use
  • Currently infected with a communicable skin infection (e.g., shingles or methicillin-resistant S. aureus), which does not include local and minimally pathogenic or non-pathogenic infections distant from the imaging location(s) (e.g., warts, acne)
  • Any known allergies to any materials used in the preparation of skin and/or device use
  • Has a temporary or permanent electrical implanted medical device
  • \-

Key Trial Info

Start Date :

March 28 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 6 2022

Estimated Enrollment :

122 Patients enrolled

Trial Details

Trial ID

NCT05410964

Start Date

March 28 2018

End Date

August 6 2022

Last Update

January 30 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Enspectra Health

Mountain View, California, United States, 94040